Literature DB >> 8981575

Methodological considerations in neurobehavioral teratology.

L P Spear1, S E File.   

Abstract

Neurobehavioral teratology is a rapidly expanding field benefitting from recent advances in neurobiology and behavior and from the increasing availability of compounds with specific pharmacological actions. There is evidence that data derived from animal studies are clinically pertinent and hence animal studies are useful in extending clinical findings, in anticipating consequences of early drug exposure and, by determining the underlying neural mechanisms, in developing therapeutic approaches. However, the usefulness of animal studies crucially depends on the reliability and sensitivity of the methods used. We highlight the importance of appropriate selection of the route, dose, frequency, duration and timing of drug administration. We also emphasize the importance of not confounding treatment with litter effects and suggest that either the litter be used as the unit of analysis, or that each litter contribute only one pup to each test condition. We discuss the question of the time of testing and of testing, not only under baseline conditions, but also in conditions in which the offspring are exposed to stressful, pharmacological or cognitive challenges. We hope that future studies will benefit from these considerations and avoid the methodological weaknesses that beset some of the early studies in this field.

Mesh:

Substances:

Year:  1996        PMID: 8981575     DOI: 10.1016/s0091-3057(96)00272-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

1.  A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity.

Authors:  Joseph Yanai; Yael Brick-Turin; Sharon Dotan; Rachel Langford; Adi Pinkas; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-02-13       Impact factor: 3.763

Review 2.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

3.  Neurobehavioral teratogenicity of sarin in an avian model.

Authors:  Joseph Yanai; Adi Pinkas; Frederic J Seidler; Ian T Ryde; Eddy A Van der Zee; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-08-03       Impact factor: 3.763

4.  Chronic tolerance to the social consequences of ethanol in adolescent and adult Sprague-Dawley rats.

Authors:  Elena I Varlinskaya; Linda P Spear
Journal:  Neurotoxicol Teratol       Date:  2006-09-09       Impact factor: 3.763

5.  An avian model for the reversal of neurobehavioral teratogenicity with neural stem cells.

Authors:  Sharon Dotan; Adi Pinkas; Theodore A Slotkin; Joseph Yanai
Journal:  Neurotoxicol Teratol       Date:  2010-03-04       Impact factor: 3.763

Review 6.  Consequences of Perinatal Cannabis Exposure.

Authors:  Andrew F Scheyer; Miriam Melis; Viviana Trezza; Olivier J J Manzoni
Journal:  Trends Neurosci       Date:  2019-10-08       Impact factor: 13.837

7.  Sensitization to social anxiolytic effects of ethanol in adolescent and adult Sprague-Dawley rats after repeated ethanol exposure.

Authors:  Elena I Varlinskaya; Linda P Spear
Journal:  Alcohol       Date:  2010-02       Impact factor: 2.405

8.  Impact of social isolation and enriched environment during adolescence on voluntary ethanol intake and anxiety in C57BL/6J mice.

Authors:  Marcelo F Lopez; Kathy Laber
Journal:  Physiol Behav       Date:  2014-11-08

9.  Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model.

Authors:  Adi Pinkas; Theodore A Slotkin; Yael Brick-Turin; Eddy A Van der Zee; Joseph Yanai
Journal:  Neurotoxicol Teratol       Date:  2009-11-27       Impact factor: 3.763

10.  To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.

Authors:  Jenny L Wiley; Rhys L Evans
Journal:  Int J Dev Neurosci       Date:  2008-11-08       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.